How does disopyramide phosphate actually stop an irregular heartbeat?
Disopyramide phosphate is a Type 1 antiarrhythmic that blocks sodium channels in heart cells, slowing the electrical signals that trigger abnormal rhythms. It also lengthens the action potential duration (the time a heart cell stays electrically active), which helps restore normal rhythm in patients with life-threatening arrhythmias [1].
In clinical trials, disopyramide phosphate decreases the rate of abnormal electrical firing (phase 4 depolarization) in overactive heart cells and slows the upstroke velocity of the electrical signal traveling through the heart. These effects suppress ectopic (out-of-place) heartbeats and restore a more orderly rhythm. The drug works similarly to older antiarrhythmics like procainamide and quinidine [1].
Inside each heart cell, disopyramide phosphate blocks the sodium channel—the gateway that lets sodium ions rush in and trigger an electrical impulse. By slowing this sodium influx, the drug dampens the heart's electrical excitability. Think of it like turning down the volume on a speaker that's been turned up too loud [1].
The trade-off is that disopyramide phosphate also has anticholinergic side effects (dry mouth, urinary retention, blurred vision) because it blocks acetylcholine receptors in the body. It can also lengthen the QT interval on an EKG, which raises the risk of a dangerous rhythm called torsades de pointes if potassium levels drop or other QT-prolonging drugs are added [1].
Ask your cardiologist to check your baseline EKG and potassium level before starting disopyramide, and repeat the EKG at 1 week and 4 weeks. Report any new shortness of breath, fainting, or chest pain immediately—these may signal a dangerous rhythm change [1].